These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6268690)

  • 1. Solubilized TSH-receptor: its usefulness for the radioligand receptor assay for TSH and TSH-displacing antibody.
    Kotulla P; Schleusener H
    J Endocrinol Invest; 1981; 4(2):155-60. PubMed ID: 6268690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells.
    Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T
    J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of TSH-binding inhibitor immunoglobulins by using the triton-solubilized receptor from human thyroid membranes.
    Iida Y; Konishi J; Kasagi K; Kuma K; Torizuka K
    Endocrinol Jpn; 1982 Apr; 29(2):227-31. PubMed ID: 6127209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of triton-solubilized TSH receptors from human thyroid plasma membranes.
    Iida Y; Konishi J; Kasagi K; Ikekubo K; Kuma K; Torizuka K
    Acta Endocrinol (Copenh); 1981 Sep; 98(1):50-6. PubMed ID: 6269343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves' disease.
    Macchia E; Fenzi GF; Monzani F; Bartalena L; Lippi F; Aloisio V; Cupini C; Baschieri L; Pinchera A
    J Endocrinol Invest; 1983 Oct; 6(5):375-8. PubMed ID: 6141201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the radioreceptor assay of TSH: the binding of 125I-TSH to the human thyroid receptor and the interaction of LATS-IgG (author's transl)].
    Endo K
    Nihon Naibunpi Gakkai Zasshi; 1979 Oct; 55(10):1249-60. PubMed ID: 228997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved radioreceptor assay for TSH receptor antibodies.
    Shewring G; Smith BR
    Clin Endocrinol (Oxf); 1982 Oct; 17(4):409-17. PubMed ID: 6291808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of different assays for the thyroid-stimulating antibody of Graves' disease.
    Loeffler M; Zakarija M; McKenzie JM
    J Clin Endocrinol Metab; 1983 Sep; 57(3):603-8. PubMed ID: 6135706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubilized human thyrotrophin receptors behave as one class of high-affinity binding sites.
    de Bruin TW; van der Heide D
    Mol Cell Endocrinol; 1984 Oct; 37(3):337-48. PubMed ID: 6094287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between thyroid-stimulating immunoglobulins and thyrotropin receptors in fat cell membranes.
    Kishihara M; Nakao Y; Baba Y; Matsukura S; Kuma K; Fujita T
    J Clin Endocrinol Metab; 1979 Nov; 49(5):706-11. PubMed ID: 226558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioreceptor assay of anti-TSH receptor antibody activity: comparison of assays using unextracted serum and immunoglobulin fractions, and standardization of expression of activities.
    Tamaki H; Amino N; Watanabe Y; Aozasa M; Hayashi H; Tachi J; Miyai K
    J Clin Lab Immunol; 1986 May; 20(1):1-6. PubMed ID: 3016274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves' disease and other thyroid disorders.
    Sugenoya A; Kidd A; Row VV; Volpé R
    J Clin Endocrinol Metab; 1979 Mar; 48(3):398-402. PubMed ID: 218990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotrophin (TSH) binding sites on Yersinia enterocolitica recognized by immunoglobulins from humans with Graves' disease.
    Heyma P; Harrison LC; Robins-Browne R
    Clin Exp Immunol; 1986 May; 64(2):249-54. PubMed ID: 3017619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies.
    Baker JR; Lukes YG; Burman KD
    J Clin Invest; 1984 Aug; 74(2):488-95. PubMed ID: 6086714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An improved assay for thyrotropin-binding blocking activity in serum of patients with Graves' disease.
    Tao TW; Kriss JP
    J Endocrinol Invest; 1984 Aug; 7(4):335-9. PubMed ID: 6150053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease.
    Shinozawa T; Villadolid MC; Ingbar SH
    J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nature of thyrotropin displacement activity in subacute thyroiditis.
    Wall JR; Strakosch CR; Bandy P; Bayly R
    J Clin Endocrinol Metab; 1982 Feb; 54(2):349-53. PubMed ID: 6274901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum unmasks the binding of thyroid-stimulating hormone to endogenous and transfected receptors: evidence for a soluble form of the receptor in human thyroid.
    Willey KP; Hunt N; Abend N; Northemann W; Ivell R; Leidenberger F
    J Endocrinol; 1993 Nov; 139(2):317-28. PubMed ID: 8308468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A receptor assay for the measurement of TSH receptor antibodies in unextracted serum.
    Southgate K; Creagh F; Teece M; Kingswood C; Rees Smith B
    Clin Endocrinol (Oxf); 1984 May; 20(5):539-48. PubMed ID: 6086180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.